Treatment Response in Patients With Medication-Overuse Headache
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorSultan 1. Murat State Hospital
About this trial
The aim of this study to evaluate pre-injection patient-related factors that may influence treatment response in patients with medication-overuse headache who underwent ultrasound-guided greater occipital nerve block.
Eligibility criteria
Qualifiers
Age between 18 and 65 years
Diagnosis of medication-overuse headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3)
Diagnosis of medication-overuse headache associated with the use of triptans or nonsteroidal anti-inflammatory drugs
Previous diagnosis of chronic migraine or chronic tension-type headache according to the ICHD-3 criteria
Disqualifiers
History of severe head or neck trauma or previous neurosurgical intervention
Presence of a severe psychiatric disorder (e.g., severe depression, schizophrenia)
History of infectious disease, chronic inflammatory disease, or malignancy
Previous diagnosis of secondary headache
Trial design
Treatments tested in this trial
- Treatment outcome
Treatment groups
70 Participants
are divided into 2 treatment groupsLocations
1Sultan 1. Murat State Hospital22030, Edirne Turkey (Türkiye)
Sponsors and collaborators
Sultan 1. Murat State Hospital
Lead sponsor
Source ClinicalTrials.gov